findmyKOL
Clinical trialNCT02514551CompletedPhase 2Interventional

A Study of Ramucirumab (LY3009806) in Combination With Paclitaxel in Participants With Gastric Cancer

SponsorEli Lilly and CompanyEnrollment245Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)

    Eli Lilly and Company

    Study Director

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

52 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Belgium
  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Brussels, Belgium

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Kortrijk, Belgium

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Namur, Belgium

Canada
  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-888-545-5972 Mon - Fri, 9 Am To 4 Pm Or 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 Am To 5 Pm Eastern Time Or Speak With Your Personal Physician.

    Calgary, Canada

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-888-545-5972 Mon - Fri, 9 Am To 4 Pm Or 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 Am To 5 Pm Eastern Time Or Speak With Your Personal Physician.

    Oshawa, Canada

Czechia
  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Brno, Czechia

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Nový Jičín, Czechia

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Prague, Czechia

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Prague, Czechia

Germany
  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Berlin, Germany

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Frankfurt am Main, Germany

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Hamburg, Germany

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Ravensburg, Germany

Greece
  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Athens, Greece

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Haidari, Greece

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Heraklion, Greece

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    N. Efkarpia, Greece

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Pátrai, Greece

Italy
  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Cagliari, Italy

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Cremona, Italy

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Faenza, Italy

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Milan, Italy

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Reggio Emilia, Italy

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    San Giovanni Rotondo, Italy

Spain
  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Barcelona, Spain

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Barcelona, Spain

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Girona, Spain

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Madrid, Spain

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Madrid, Spain

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Málaga, Spain

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Santander, Spain

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Seville, Spain

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Valencia, Spain

Sweden
  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Gothenburg, Sweden

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Linköping, Sweden

Turkey (Türkiye)
  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Ankara, Turkey (Türkiye)

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Edirne, Turkey (Türkiye)

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Istanbul, Turkey (Türkiye)

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Kayseri, Turkey (Türkiye)

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Malatya, Turkey (Türkiye)

12 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
12 Oct 2015
Primary completion
27 Oct 2017
Completion
28 Dec 2018
Last update posted
17 Jun 2020
Registered enrollment
245
Registry id
NCT02514551

Cross-registrations

EU-CTR / CTIS (EudraCT)2014-005067-32

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.